Burning Rock Biotech Ltd (BNR) stock
BNRNasdaqServices-Medical Laboratories
$13.24−0.08 (-0.60%)
Close on Nov 20, 2026Market cap $144.13MP/E –Yield –
Burning Rock Biotech net income
Net income is the profit left for shareholders after every expense, interest and tax.
For fiscal 2025 it was -CN¥55.35M. The highest annual figure on record is -CN¥55.35M in fiscal 2025.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -CN¥55.35M | – |
| FY2024 | Dec 31, 2024 | -CN¥346.63M | – |
| FY2023 | Dec 31, 2023 | -CN¥653.69M | – |
| FY2022 | Dec 31, 2022 | -CN¥971.23M | – |
| FY2021 | Dec 31, 2021 | -CN¥796.70M | – |
| FY2020 | Dec 31, 2020 | -CN¥407.24M | – |
| FY2019 | Dec 31, 2019 | -CN¥169.16M | – |
| FY2018 | Dec 31, 2018 | -CN¥177.50M | – |
See a number that looks wrong?